Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

786 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 172
Recruiting: 93
Ph III recruiting: 9
Growth YoY: +32.4%
Industry share: 20%
Top sponsor: Ruijin Hospital
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (129)

clinicaltrialsPublishedShowing 51–100 of 269 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01846390	Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma	completed	Phase 1	21	Canadian Cancer Trials GroupNETWORK	1	Mar 27, 2026	clinicaltrials
NCT03590574	Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma	terminated	Phase 1 / Phase 2	20	Autolus LimitedINDUSTRY	2	Mar 16, 2026	clinicaltrials